Your account is not claimed yet. You can sign up with ORCID to claim your account.

Guilherme Rabinowits

Years Active: 2018-2023
Publications (10 Years): 3

Miami Cancer Institute/Baptist Health South Florida

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Miami Cancer Institute/Baptist Health South Florida Jan 28o 2018

United States

Co-Leader, Head and Neck Disease Management Team :: Hematology Oncology

Publications

Meenakkshy Manoharan, Noah S Kalman, Guilherme Rabinowits
Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-Up. The oncologist (2023)
Mansoor N Saleh, Manish R Patel, Todd M Bauer, Sanjay Goel, Gerald S Falchook, Geoffrey I Shapiro, Ki Y Chung, Jeffrey R Infante, Robert M Conry, Guilherme Rabinowits, David S Hong, Judy S Wang, Ulrich Steidl, Gurudatta Naik, Vincent Guerlavais, Vojislav Vukovic, D Allen Annis, Manuel Aivado, Funda Meric-Bernstam
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Guilherme Rabinowits, Cecilia Lezcano, Paul J Catalano, Patricia McHugh, Hailey Becker, Megan M Reilly, Julian Huang, Ayushi Tyagi, Manisha Thakuria, Scott C Bresler, Lynette M Sholl, Geoffrey I Shapiro, Robert Haddad, James A DeCaprio
Cabozantinib in Patients with Advanced Merkel Cell Carcinoma. The oncologist 23 (7) (2018)

Guilherme Rabinowits.css-eqlu8i{font-size:small;padding-left:4px;}